News | 14 November 2012
The grades of four Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an ?A? (?strong buy?) or ?B? overall (?buy?) rating. This week, Incyte Corp. (NASDAQ:INCY) is showing significant ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)